Search Results - "Lam, Mei Ho"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Development and validation of an UPLC–MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair by Drooger, Jan C., Jager, Agnes, Lam, Mei-Ho, den Boer, Mathilda D., Sleijfer, Stefan, Mathijssen, Ron H.J., de Bruijn, Peter

    “…•Analysis of hair segments is a non-invasive method for measuring drug levels over time.•Adequate managing of hair samples before performing the analyses is…”
    Get full text
    Journal Article
  3. 3

    Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation by de Jonge, Maja J.A, Slingerland, Marije, Loos, Walter J, Wiemer, Erik A.C, Burger, Herman, Mathijssen, Ron H.J, Kroep, Judith R, den Hollander, Margret A.G, van der Biessen, Diane, Lam, Mei-Ho, Verweij, Jaap, Gelderblom, Hans

    Published in European journal of cancer (1990) (01-11-2010)
    “…Abstract Purpose To evaluate the safety and tolerability of LiPlaCis, a liposomal formulated platinum compound, in patients with solid tumours and to determine…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: A practical solution for non-specific binding by de Bruijn, Peter, de Graan, Anne-Joy M., Nieuweboer, Annemieke, Mathijssen, Ron H.J., Lam, Mei-Ho, de Wit, Ronald, Wiemer, Erik A.C., Loos, Walter J.

    “…► LC–MS/MS method for the quantitation of cabazitaxel in human plasma. ► Practical solution for non-specific binding. ► Validated according to the guidance of…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch by Binkhorst, Lisette, Bannink, Marjolein, de Bruijn, Peter, Ruit, Jan, Droogendijk, Helga, van Alphen, Robbert J., den Boer, Tilly D., Lam, Mei Ho, Jager, Agnes, van Gelder, Teun, Mathijssen, Ron H. J.

    Published in Clinical pharmacokinetics (01-02-2016)
    “…Background and Objective The anti-oestrogen tamoxifen requires metabolic activation to endoxifen by cytochrome P450 (CYP) enzymes, predominantly CYP2D6. Potent…”
    Get full text
    Journal Article